Bayer Research and Development Expenses 2010-2024 | BAYRY

Bayer research and development expenses for the twelve months ending September 30, 2024 were $5.738B, a 9.12% decline year-over-year.

  • Bayer annual research and development expenses for 2023 were $5.813B, a 16.05% decline from 2022.
  • Bayer annual research and development expenses for 2022 were $6.924B, a 8.14% increase from 2021.
  • Bayer annual research and development expenses for 2021 were $6.403B, a 21.34% decline from 2020.

Bayer Research and Development Expenses 2010-2024 | BAYRY

  • Bayer annual research and development expenses for 2023 were $5.813B, a 16.05% decline from 2022.
  • Bayer annual research and development expenses for 2022 were $6.924B, a 8.14% increase from 2021.
  • Bayer annual research and development expenses for 2021 were $6.403B, a 21.34% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$759.4B
Novo Nordisk (NVO)$387.1B
Johnson & Johnson (JNJ)$342B
AbbVie (ABBV)$309.5B
Merck (MRK)$251.1B
AstraZeneca (AZN)$207.8B
Novartis AG (NVS)$202.5B
Pfizer (PFE)$151.4B
Sanofi (SNY)$123.7B
Innoviva (INVA)$1.1B